Femasys announces partnership with carolinas fertility institute, one of america's best fertility clinics, to offer femaseed® in its more than 8 locations

-- femasys continues to expand access and market share for its first-line infertility treatment option, femaseed® -- atlanta, june 11, 2025 (globe newswire) -- femasys, inc., (nasdaq: femy), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products announces a partnership with carolinas fertility institute (cfi), one of america's best fertility clinics. carolinas fertility institute will provide the company's femaseed® intratubal insemination product as an infertility treatment option to patients throughout its network in north carolina.
FEMY Ratings Summary
FEMY Quant Ranking